21P Circulating free and extracellular vesicles-derived microRNA as prognostic biomarkers in resected early-stage non-small cell lung cancer

MLA

P. Ulivi, et al. “21P Circulating Free and Extracellular Vesicles-Derived MicroRNA as Prognostic Biomarkers in Resected Early-Stage Non-Small Cell Lung Cancer.” Annals of Oncology, vol. 33, Sept. 2022, pp. S552–53. EBSCOhost, https://doi.org/10.1016/j.annonc.2022.07.049.

APA

P. Ulivi, L. Pasini, E. Petracci, M. Urbini, E. Felip, F. Stella, F. Davoli, M. Salvi, M. Beau-Faller, M. Tebaldi, I. Azzali, P. Solli, G. Lai, R. Amat, C. Carbonell, A. Martinez-Marti, E. Pencreach, A. Delmonte, & L. Crinò. (2022). 21P Circulating free and extracellular vesicles-derived microRNA as prognostic biomarkers in resected early-stage non-small cell lung cancer. Annals of Oncology, 33, S552–S553. https://doi.org/10.1016/j.annonc.2022.07.049

Chicago

P. Ulivi, L. Pasini, E. Petracci, M. Urbini, E. Felip, F. Stella, F. Davoli, et al. 2022. “21P Circulating Free and Extracellular Vesicles-Derived MicroRNA as Prognostic Biomarkers in Resected Early-Stage Non-Small Cell Lung Cancer.” Annals of Oncology 33 (September): S552–53. doi:10.1016/j.annonc.2022.07.049.